The Quantellect read.As of Nov 19, 2026, 9 active firms cover Laboratory Corporation of America Holdings: 7 rate it Buy or better, 2 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $300.00 to $380.00, so the covering firms are broadly aligned. The average target of $337.78 sits 9% below the current $370.84. The rating mix has stayed broadly stable, with Buy-side ratings easing from 8 to 7 over recent months. On the fundamentals, the Street sees consensus EPS building from about $4.54 next quarter toward $19.60 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 active firms
Buy
Strong Buy00%
Buy778%
Neutral222%
Sell00%
Strong Sell00%
Based on 9 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$337.78
-8.9% downside
Average target across 9 active firms as of Nov 19, 2026 vs $370.84 current
Highest Target$380.00
Average Target$337.78
Lowest Target$300.00
Detailed analyst forecasts for LH
Showing 1–10 of 10 named analysts shown · 9 active firms in the rating projection
As of Nov 19, 2026, 7 of 9 active firms rate LH a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
LH EPS & revenue forecast
EPS · NEXT QUARTER
$4.54
Range $4.26 – $4.79 · 10 analysts · +7% YoY
Next period, 10 analysts expect Laboratory Corporation of America Holdings to earn $4.54 a share (range $4.26 – $4.79), versus $4.25 a year earlier. Full-year consensus is $18.49, growing to $19.60 the year after.
REVENUE · NEXT QUARTER
$3.7B
Range $3.7B – $3.8B · 10 analysts · +5% YoY
Revenue is expected to reach $3.7B (range $3.7B – $3.8B), +5.5% year-over-year. Full-year consensus is $14.8B, rising to $15.6B next year.
Top analysts covering Laboratory Corporation of America Holdings
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on LH.
#1
Erin Wright
Morgan Stanley · Rank #81
Buy
$338.00-8.9% to target
Overall win rate
55%
+ Follow
#2
DM
David Macdonald
Truist Securities · Rank #111
Buy
$365.00-1.6% to target
Overall win rate
50%
+ Follow
#3
EC
Eric Coldwell
Baird · Rank #127
Buy
$352.00-5.1% to target
Overall win rate
37%
+ Follow
#4
Kevin Caliendo
UBS · Rank #165
Buy
$420.00+13.3% to target
Overall win rate
42%
+ Follow
#5
Luke Sergott
Barclays · Rank #267
Neutral
$380.00+2.5% to target
Overall win rate
43%
+ Follow
LH stock forecast FAQ
What is LH's average 12-month price target?+
The 9 active firms with a live target average $337.78 for Laboratory Corporation of America Holdings over the next 12 months, ranging from a $380.00 high to a $300.00 low, as of Nov 19, 2026.
Is LH stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 9 active firms as of Nov 19, 2026, 7 rate it Buy or Strong Buy, 2 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for LH?+
The Street-high target is $380.00 (UBS), and the Street-low is $300.00 (Evercore ISI Group). The average of all 9 active-firm targets is $337.78.
How many active Wall Street firms cover LH?+
9 active firms have a recognized rating on Laboratory Corporation of America Holdings as of Nov 19, 2026, and 9 active firms carry a live 12-month price target.
Who is the most accurate analyst covering LH?+
Among analysts who currently cover LH, Erin Wright of Morgan Stanley has the strongest overall Quantellect track record (Rank #81). Their current call is Buy with a $338.00 target.
What is Laboratory Corporation of America Holdings's projected EPS for next quarter?+
The consensus estimate is $4.54 per share (range $4.26 – $4.79) across 10 analysts. Full-year EPS is projected at $18.49, rising to $19.60 the following year.
How much revenue is Laboratory Corporation of America Holdings expected to report next quarter?+
Consensus revenue is $3.7B (range $3.7B – $3.8B). Full-year revenue is projected at $14.8B, growing to $15.6B next year.
Have analysts been upgrading or downgrading LH lately?+
As of Nov 19, 2026, 7 of 9 active firms rate LH a Buy (2 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.